Tekmira Pharma (TKMR) Posts Wider than Expected Q2 Loss of 28c/Share; Expects FDA Hold to Resolved by Q4 2014

Go back to Tekmira Pharma (TKMR) Posts Wider than Expected Q2 Loss of 28c/Share; Expects FDA Hold to Resolved by Q4 2014

Tekmira Pharmaceuticals (TKMR) to resume trading at 5PM ET following earnings and program update

August 13, 2014 4:37 PM EDT

Tekmira Pharmaceuticals (NASDAQ: TKMR) to resume trading at 5PM ET following earnings and program update.

NOTE: Some are viewing the halt as an amateur move.

... More

Ebola Stocks on Watch With Tekmira Pharmaceuticals (TKMR) Halted

August 13, 2014 4:28 PM EDT

Ebola stocks on watch with Tekmira Pharmaceuticals (NASDAQ: TKMR) halts for trading with news pending.

Other Ebola stocks: BioCryst (NASDAQ: BCRX), NanoViricides, Inc. (NYSE: NNVC), Sarepta Therapeutics (Nasdaq: SRPT), NewLink Genetics (NASDAQ: NLNK).

... More

Tekmira Pharmaceuticals (TKMR) trading halted with news pending

August 13, 2014 4:25 PM EDT

Tekmira Pharmaceuticals (NASDAQ: TKMR) trading halted with news pending.

... More